phantasmidine (NIDDK)

N/A

Report date: 2025/03/20 09:27:44
NME

Base Information

Drug Namephantasmidine (NIDDK)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta-4 nicotinic acetylcholine receptor agonists
TargetsBeta-4 nicotinic acetylcholine receptor
Therapy Area/IndicationsSubstance-Related DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Institute Of Diabetes And Digestive And Kidney Diseases
Inactive CompaniesN/A
Active IndicationsSubstance-Related DisordersNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A